BIO 2026: CQDM and Investissement Québec bring the ecosystem together to drive biopharmaceutical R&D collaborations
On the sidelines of BIO 2026, CQDM and Investissement Québec International brought together more than 100 life sciences stakeholders for a reverse pitch session aimed at accelerating biopharmaceutical R&D collaborations. A format designed to align industry needs with innovation The reverse pitch format enables large pharmaceutical companies to present their priorities and R&D needs directly…